Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank41
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -15.88% |
| Q2 2025 | 18.89% |
| Q1 2025 | -2.32% |
| Q4 2024 | 4.49% |
| Q3 2024 | 2.24% |
| Q2 2024 | 22.82% |
| Q1 2024 | -2208.80% |
| Q4 2023 | 105.75% |
| Q3 2023 | -1.31% |
| Q2 2023 | 12.21% |
| Q1 2023 | -28.66% |
| Q4 2022 | 10.14% |
| Q3 2022 | -16.50% |
| Q2 2022 | -240.61% |
| Q1 2022 | -23.41% |
| Q4 2021 | 254.18% |
| Q3 2021 | 52.83% |
| Q2 2021 | -25.02% |
| Q1 2021 | -23.78% |
| Q4 2020 | -65.35% |
| Q3 2020 | 15.65% |
| Q2 2020 | -12.67% |
| Q1 2020 | -266.74% |
| Q4 2019 | 128.34% |
| Q3 2019 | 39.91% |
| Q2 2019 | 20.57% |
| Q1 2019 | 47.88% |
| Q4 2018 | -23.30% |
| Q3 2018 | -0.77% |
| Q2 2018 | -25.02% |
| Q1 2018 | -5.95% |
| Q4 2017 | -9.65% |
| Q3 2017 | -16.55% |
| Q2 2017 | -2.43% |
| Q1 2017 | -74.91% |
| Q4 2016 | -1.19% |
| Q3 2016 | -16.30% |
| Q2 2016 | -24.73% |
| Q1 2016 | -14.09% |
| Q4 2015 | -22.28% |